Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 227

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study

Open access
Wilkinson, Thomas J., Miksza, Joanne, Yates, Thomas, Lightfoot, Courtney J., Baker, Luke A., Watson, Emma L., Zaccardi, Francesco, Smith, Alice C. · 2021 · Journal of Cachexia, Sarcopenia and Muscle

Abstract

Background: Sarcopenia, a degenerative and generalized skeletal muscle disorder involving the loss of muscle function and mass, is an under‐recognized problem in clinical practice, particularly in chronic kidney disease (CKD). We aimed to investigate the prevalence of sarcopenia in individuals with CKD, its risk factors, and its association with all‐cause mortality and progression to end‐stage renal disease (ESRD). Methods: UK Biobank participants were grouped according to the presence of CKD (defined as an estimated glomerular filtration rate <60 mL/min/1.73 m 2 ) and as having probable (low handgrip strength), confirmed (plus low muscle mass), and severe sarcopenia (plus poor physical performance) based on the 2019 European Working Group of Sarcopenia in Older People and Foundation for the National Institutes of Health criteria. Risk factors were explored using logistic regression analysis. Survival models were applied to estimate risk of mortality and ESRD. Results: A total of 428 320 participants, of which 8767 individuals with CKD (46% male, aged 62.8 (standard deviation 6.8) years, median estimated glomerular filtration rate 54.5 (interquartile range 49.0–57.7) mL/min/1.72 m 2 ) were included. Probable sarcopenia was present in 9.7% of individuals with CKD compared with 5.0% in those without ( P < 0.001). Sarcopenia was associated with being older; inflammation; poorer renal function; and lower serum albumin, total testosterone, and haemoglobin. The largest risk factors for sarcopenia were having three or more comorbidities (odds ratio: 2.30; 95% confidence interval: 1.62 to 3.29; P < 0.001) and physical inactivity: participants in the highest quartile of weekly activity were 43% less likely to have sarcopenia compared to the lowest quartile (odds ratio: 0.57; 0.42 to 0.76; P < 0.001). Participants with CKD and sarcopenia had a 33% (7% to 66%; P = 0.011) higher hazard of mortality compared with individuals without. Sarcopenic CKD individuals had a 10 year survival probability of 0.85 (0.82 to 0.88) compared with 0.89 (0.88 to 0.30) in those without sarcopenia, an absolute difference of 4%. Those with sarcopenia were twice as likely to develop ESRD (hazard ratio: 1.98; 1.45 to 2.70; P < 0.001). Conclusions: Participants with reduced kidney function are at an increased risk of premature mortality. The presence of sarcopenia increases the risk of mortality and ESRD. Appropriate measurement of sarcopenia should be used to identify at‐risk individuals. Interventions such as physical activity should be encouraged to mitigate sarcopenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcsm.12705

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 49

  1. 10.1016/S0140-6736(19)31138-9 · DOI · Paper page
  2. 10.1111/jgs.16575 · DOI
  3. 10.1371/journal.pone.0169548 · DOI · Paper page
  4. 10.1016/j.clnu.2018.09.026 · DOI
  5. 10.1093/gerona/glu013 · DOI · Paper page
  6. 10.22540/JFSF-04-071 · DOI
  7. 10.1097/MNH.0000000000000318 · DOI · Paper page
  8. 10.1053/j.ajkd.2017.01.051 · DOI · Paper page
  9. 10.1093/ndt/gft070 · DOI · Paper page
  10. 10.1371/journal.pone.0176230 · DOI · Paper page
  11. 10.5812/numonthly.37443 · DOI
  12. 10.3109/0886022X.2015.1132173 · DOI · Paper page
  13. 10.1111/nep.13678 · DOI
  14. 10.2215/CJN.10261013 · DOI · Paper page
  15. 10.1016/j.clnu.2013.04.002 · DOI · Paper page
  16. 10.1186/s12882-019-1271-8 · DOI
  17. 10.3904/kjim.2017.083 · DOI
  18. 10.1016/j.ekir.2016.10.008 · DOI
  19. 10.1016/j.nut.2020.110815 · DOI
  20. 10.1681/ASN.2012070702 · DOI · Paper page
  21. 10.3390/nu11061378 · DOI
  22. 10.1111/j.1523-1755.2005.00365.x · DOI · Paper page
  23. 10.1002/jcsm.12503 · DOI · Paper page
  24. 10.1016/j.jamda.2014.11.004 · DOI
  25. 10.1017/jns.2017.66 · DOI · Paper page
  26. 10.1002/sim.1203 · DOI · Paper page
  27. 10.1093/ndt/gfw466 · DOI
  28. 10.1093/ndt/gfv133 · DOI · Paper page
  29. 10.1007/s41999-020-00310-5 · DOI
  30. 10.1007/s00223-013-9830-7 · DOI · Paper page
  31. 10.1093/ageing/afaa077 · doi:10.1093/ageing/afaa077
  32. 10.1093/ajcn/81.1.79 · DOI · Paper page
  33. 10.1093/ndt/17.7.1266 · DOI · Paper page
  34. 10.1093/ndt/gfq487 · doi:10.1093/ndt/gfq487
  35. 10.1186/s12882-020-01831-8 · DOI
  36. 10.1093/ndt/gfr013 · DOI
  37. 10.1177/2047487319885041 · DOI
  38. 10.1096/fj.201901936RR · DOI
  39. 10.1002/ajhb.20956 · DOI · Paper page
  40. 10.1159/000101827 · DOI · Paper page
  41. 10.1016/j.metabol.2016.07.003 · DOI
  42. Wilkinson TJ, 2017, Commentary: Renal function estimation and Cockcroft‐Gault formulas for predicting cardiovascular mortality in population‐based, cardiovascular risk, heart failure and post‐myocardial infarction cohorts: the Heart ‘OMics’ in AGEing (HOMAGE) and the high‐risk myocardial infarction database initiatives, Front Med (Lausanne), 4, 77, 10.3389/fmed.2017.00077 · doi:10.3389/fmed.2017.00077
  43. 10.1016/j.jamda.2018.06.011 · DOI
  44. 10.1016/j.maturitas.2016.11.006 · DOI · Paper page
  45. 10.1016/S0272-6386(03)00654-1 · DOI · Paper page
  46. 10.1002/jcsm.12218 · DOI
  47. 10.1093/ndt/gfz235 · DOI · Paper page
  48. 10.2147/CIA.S132940 · DOI · Paper page
  49. 10.1002/jcsm.12501 · DOI · Paper page

Metadata

Authors
Wilkinson, T. J., Miksza, J., Yates, T., Lightfoot, C. J., Baker, L. A., Watson, E. L., Zaccardi, F., & Smith, A. C.
Venue
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Published
2021-05-05
Volume
12
Issue
3
Pages
586-598
ISSN
  • 2190-5991 (ISSN-L)
  • 2190-6009
OpenAlex
W3158761451
Cited by
227
References
14
FWCI
16.19
Type
journal article
Language
en
Open access
gold
Funders
  • British Heart Foundation
  • Northwest Regional Development Agency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study. https://app.cochat.ai/papers/10.1002/jcsm.12705
The paper
Wilkinson, T. J., Miksza, J., Yates, T., Lightfoot, C. J., Baker, L. A., Watson, E. L., Zaccardi, F., & Smith, A. C. (2021). Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.12705

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.